US EditionPublished • loading... • Updated
Hangzhou Jiuge Biotech advances membrane protein production with P2X1 antibody P007
Summary by London-globe.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Hangzhou Jiuge Biotech advances membrane protein production with P2X1 antibody P007
Hangzhou Jiuge Biotech’s innovative membrane protein production technology creates collaboration opportunities for the European pharmaceutical industry. (Source: Hangzhou Jiuge Biotech) Amid rising R&D costs and increasing innovation challenges in the global pharmaceutical industry, Hangzhou Jiuge Biotech, a Chinese biotech company, has achieved a significant breakthrough in membrane protein production, opening new possibilities for international
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
